In December 2024, Novo Nordisk announced that the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings was completed.
Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new facilities, strategically positioned across key global markets ...